Mistletoe and the Emerging Future of Integrative OncologyWith 100 years of continuous use and backed by 250 randomized studies, it is the most studied integrative oncology therapy in the world – and utilized in upward of 60% to 80% of patients in Europe. Why is there so much resistance in the United…

Mistletoe and the Emerging Future of Integrative OncologyWith 100 years of continuous use and backed by 250 randomized studies, it is the most studied integrative oncology therapy in the world – and utilized in upward of 60% to 80% of patients in Europe. Why is there so much resistance in the United…

Source: Original Article

Publish Date: 2022-05-31 03:33:32